BUFFALO, NY, October 18, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. XXIIa leading agricultural biotechnology company dedicated to improving health through advanced nicotine-reduced plant technologies in tobacco, hemp/cannabis and hops, announced today that James A. Mish, Chief Executive Officer, at LD Micro Main Event Investor Conference in Los Angeles, California on Wednesday, October 26, 2022 at 11:00 a.m. PT.

Due to the high demand, space for investor talks is limited. Institutional investors attending the conference may request to meet with management through their LD Micro representative or by contacting 22nd Century Group’s Investor Relations team investorrelations@xxiicentury.com.

The live and archived webcast of the presentation will be available on the Events section of 22nd Century Group’s Investor Relations website at https://www.xxiicentury.com/investors/events. An archived replay of the webcast will also be available shortly after the live event concludes.

About 22nd Century Group, Inc.
22nd Century Group, Inc. XXII is a leading agricultural biotechnology company focused on reducing tobacco harm, reducing nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the company has developed proprietary tobacco plants and reduced nicotine (RNC) cigarettes that have become the cornerstone of the Comprehensive plan of the FDA to address the widespread deaths and diseases caused by smoking. The company received the first and only FDA MRTP approval for a combustible cigarette in December 2021. In tobacco, hemp/cannabis and hop crops, 22nd Century uses advanced plant breeding technologies, including genetic engineering, gene editing and molecular breeding, to deliver solutions to the life science and consumer products industries by creating new, proprietary crops with optimized alkaloid and flavonoid profiles…